LUMABS BV
PrivateCompany Overview
LUMABS BV is a biotechnology company that develops next-generation bioluminescence-based immunoassay platforms for rapid, sensitive, and quantitative biomolecule detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LUMABS BV Comparables
Compare LUMABS BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioAuxilium Technologies | 77% | |
| Revvity, Inc. | 70% | |
| Promega Corporation | 70% |
LUMABS BV Funding Rounds
Historical fundraising activity
LUMABS BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors grew 310% MoM, reaching 1.7K.
LUMABS BV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LUMABS BV's valuation, stock price, and market status.
Is LUMABS BV a public or private company?
LUMABS BV is a private company.
What is the current stock price of LUMABS BV?
LUMABS BV is a private company with no public stock price. No recent secondary market data is available.
How much is LUMABS BV worth (valuation)?
Valuation information for LUMABS BV is not publicly available.
Can I buy LUMABS BV stock?
LUMABS BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LUMABS BV's last funding round?
Funding round information for LUMABS BV is not publicly available.
Who are the main investors in LUMABS BV?
Key investors in LUMABS BV include NLC Health Ventures.
Will LUMABS BV IPO soon?
No public IPO plans have been announced for LUMABS BV.
How can I track LUMABS BV secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LUMABS BV's secondary market activity and sign up for updates.